Publication | Closed Access

Mefloquine and its oxazolidine derivative compound are active against drug-resistant Mycobacterium tuberculosis strains and in a murine model of tuberculosis infection

Pulmonary TuberculosisHealth SciencesMedicineMurine ModelOxazolidine Derivative CompoundTuberculosisAntibacterial AgentAntimicrobial ChemotherapyAntimicrobial CompoundPharmacologyClinical MicrobiologyAntimicrobial ResistanceDrug DiscoveryTuberculosis InfectionDrug Resistance